Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor

被引:85
作者
Sreeramaneni, R
Chaudhry, A
McMahon, M
Sherr, CJ
Inoue, K
机构
[1] Wake Forest Univ, Dept Pathol, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Dept Canc Biol, Winston Salem, NC 27157 USA
[3] Univ Calif San Francisco, Inst Canc Res, Zion Comprehens Canc Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Zion Comprehens Canc Ctr, San Francisco, CA 94143 USA
[5] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA
关键词
D O I
10.1128/MCB.25.1.220-232.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dmp1 prevents tumor formation by activating the Arf-p53 pathway. In cultured primary cells, the Dmp1 promoter was efficiently activated by oncogenic Ha-Ras(V12), but not by overexpressed c-Myc or E2F-1. Dmp1 promoter activation by Ras(V12) depended on Raf-MEK-ERK signaling. Induction of p19(Arf) and p21(Cip1) by oncogenic Raf was compromised in Dmp1-null cells, which were resistant to Raf-mediated premature senescence. A Ras(V12)-responsive element was mapped to the 5' leader sequence of the murine Dmp1 promoter, where endogenous Fos and Jun family proteins bind. Dmp1 promoter activation by Ras(V12) was strikingly impaired in c-Jun as well as in JunB knock-down cells, suggesting the critical role of Jun proteins in the activation of the Dmp1 promoter. A Ras(V12)-responsive element was mapped to the unique Dmp1/Ets site on the Arf promoter, where endogenous Dmp1 proteins bind upon oncogenic Raf activation. Therefore, activation of Arf by Ras/Raf signaling is indirectly mediated by Dmp1, explaining why Dmp1-null primary cells are highly susceptible to Ras-induced transformation. Our data indicate the presence of the novel Jun-Dmp1 pathway that directly links oncogenic Ras-Raf signaling and p19(Arf), independent of the classical cyclin D1/Cdk4-Rb-E2F pathway.
引用
收藏
页码:220 / 232
页数:13
相关论文
共 56 条
[1]   TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS [J].
ALBANESE, C ;
JOHNSON, J ;
WATANABE, G ;
EKLUND, N ;
VU, D ;
ARNOLD, A ;
PESTELL, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23589-23597
[2]  
ALEXANDROPOULOS K, 1992, CELL GROWTH DIFFER, V3, P731
[3]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[4]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .10. THE RAS GENE FAMILY AND HUMAN CARCINOGENESIS [J].
BOS, JL .
MUTATION RESEARCH, 1988, 195 (03) :255-271
[5]   GENETIC CHANGES IN SKIN TUMOR PROGRESSION - CORRELATION BETWEEN PRESENCE OF A MUTANT RAS GENE AND LOSS OF HETEROZYGOSITY ON MOUSE CHROMOSOME-7 [J].
BREMNER, R ;
BALMAIN, A .
CELL, 1990, 61 (03) :407-417
[6]   SERUM-INDUCED, TPA-INDUCED, AND RAS-INDUCED EXPRESSION FROM AP-1/ETS-DRIVEN PROMOTERS REQUIRES RAF-1 KINASE [J].
BRUDER, JT ;
HEIDECKER, G ;
RAPP, UR .
GENES & DEVELOPMENT, 1992, 6 (04) :545-556
[7]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[8]   Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts [J].
Chadee, DN ;
Hendzel, MJ ;
Tylipski, CP ;
Allis, CD ;
Bazett-Jones, DP ;
Wright, JA ;
Davie, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (35) :24914-24920
[9]   Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) [J].
Cheng, MG ;
Sexl, V ;
Sherr, CJ ;
Roussel, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) :1091-1096
[10]   ACTIVATION OF MAP KINASE KINASE IS NECESSARY AND SUFFICIENT FOR PC12 DIFFERENTIATION AND FOR TRANSFORMATION OF NIH 3T3 CELLS [J].
COWLEY, S ;
PATERSON, H ;
KEMP, P ;
MARSHALL, CJ .
CELL, 1994, 77 (06) :841-852